Ching-Ming Chien Selected Research

Naja naja atra cardiotoxin III

6/2007

Involvement of c-jun N-terminal kinase in G2/M arrest and caspase-mediated apoptosis induced by cardiotoxin III (Naja naja atra) in K562 leukemia cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ching-Ming Chien Research Topics

Disease

14	Neoplasms (Cancer) 02/2019 - 03/2006
8	Leukemia 11/2008 - 04/2005
4	Breast Neoplasms (Breast Cancer) 01/2019 - 02/2010
3	Squamous Cell Carcinoma of Head and Neck 09/2010 - 10/2009
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2019 - 01/2018
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 05/2014 - 10/2009
2	Adenocarcinoma of Lung 01/2010 - 09/2009
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022
1	Skin Diseases (Skin Disease) 01/2022
1	Myotonic Dystrophy (Dystrophia Myotonica) 01/2020
1	Triple Negative Breast Neoplasms 01/2019
1	Wounds and Injuries (Trauma) 01/2019
1	Diabetic Foot 01/2016
1	Diabetes Mellitus 01/2016
1	Type 2 Diabetes Mellitus (MODY) 01/2016
1	Diabetic Angiopathies (Diabetic Angiopathy) 01/2016
1	Neoplasm Metastasis (Metastasis) 01/2012
1	Colorectal Neoplasms (Colorectal Cancer) 03/2006

Drug/Important Bio-Agent (IBA)

7	CardiotoxinsIBA 01/2012 - 04/2005
4	N-formyl-13-dihydrocarminomycin (NFD)IBA 02/2019 - 01/2010
4	DiaminesIBA 09/2009 - 11/2006
4	Antineoplastic Agents (Antineoplastics)IBA 11/2008 - 11/2006
3	furanIBA 06/2010 - 01/2010
3	Peptides (Polypeptides)IBA 10/2009 - 06/2007
3	VenomsIBA 10/2009 - 06/2007
2	Proteins (Proteins, Gene)FDA Link 01/2018 - 06/2007
2	Cobra Cardiotoxin ProteinsIBA 09/2010 - 06/2010
2	ErbB Receptors (EGF Receptor)IBA 06/2010 - 10/2009
2	Caspase 3 (Caspase-3)IBA 11/2009 - 08/2006
2	Amino Acids FDA Link 10/2009 - 06/2007
2	CaspasesIBA 06/2007 - 03/2006
1	Interleukin-17 (Interleukin 17)IBA 01/2022
1	Imiquimod (Aldara)FDA LinkGeneric 01/2022
1	Interleukin-22 (IL-22)IBA 01/2022
1	CytokinesIBA 01/2022
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2022
1	VanadiumIBA 01/2022
1	AcridinesIBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	PhytochemicalsIBA 02/2019
1	Type II DNA Topoisomerases (Topoisomerase II)IBA 02/2019
1	trioctyl phosphine oxide (TOPO)IBA 02/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	4-cymene (p-cymene)IBA 01/2019
1	Hyaluronic Acid (Hyaluronan)IBA 01/2019
1	pyrazoleIBA 01/2019
1	Povidone-Iodine (Betadine)FDA LinkGeneric 01/2019
1	Endothelin-1 (Endothelin 1)IBA 01/2016
1	Lipid PeroxidesIBA 01/2016
1	furano-1,2-naphthoquinoneIBA 05/2014
1	p38 Mitogen-Activated Protein KinasesIBA 01/2012
1	WortmanninIBA 01/2012
1	SB 203580IBA 01/2012
1	src-Family KinasesIBA 09/2010
1	chloroacetaldehydeIBA 06/2010
1	lawsoneIBA 06/2010
1	Epidermal Growth Factor (EGF)IBA 06/2010
1	Cytochromes c (Cytochrome c)IBA 11/2009
1	Mitogen-Activated Protein KinasesIBA 09/2009
1	NF-kappa B (NF-kB)IBA 01/2009
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2009
1	PhosphatidylserinesIBA 01/2009
1	Mitogen-Activated Protein Kinase 3IBA 11/2008
1	Cyclin D1IBA 11/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2008
1	4- (4- dihexadecylaminostyryl)- N- methylpyridium (DiA)IBA 10/2008
1	aniline (aniline hydrobromide)IBA 08/2008
1	Pharmaceutical PreparationsIBA 06/2007
1	AcidsIBA 06/2007
1	JNK Mitogen-Activated Protein KinasesIBA 06/2007
1	Naja naja atra cardiotoxin IIIIBA 06/2007
1	(Z)- 2- (6- (thieanisyl- 2- yl)hexa- 3- en- 1,5- diynyl)benzenamineIBA 02/2007
1	GTP-Binding Proteins (G-Protein)IBA 08/2006

Therapy/Procedure

1	Photochemotherapy (Photodynamic Therapy) 01/2022
1	Therapeutics 01/2018
1	Surgical Amputation (Amputations) 01/2016